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Food-deprivedIn an attempt to establish a relationship between food intake and fear/anxiety-related behaviours, the goal of
this study was to investigate the effect of bilateral injections of GABAA (Muscimol, MUS, doses 25 and 50 ng/
side) and GABAB (Baclofen, BAC, doses 32 and 64 ng/side) receptor agonists in the nucleus accumbens shell
(AcbSh) on the level of fear/anxiety-like and feeding behaviours in 24 h food-deprived rats. The antagonists
of GABAA (Bicuculline, BIC, doses 75 and 150 ng/side) and GABAB (Saclofen, SAC, doses 1.5 and 3 μg/side)
were also tested. The results indicated that the total number of risk assessment behaviour decreased after
the injection of both doses of GABAA agonist (MUS) into the AcbSh of 24 h food-deprived rats exposed to el-
evated plus maze. Similar results were obtained after treatment with both doses of GABAB (BAC) agonist in
the AcbSh. These data indicated that the activation of both GABAA and GABAB receptors within the AcbSh
caused anxiolysis in 24 h food-deprived rats. In addition, feeding behaviour (food intake, feeding latency
and feeding duration) remained unchanged after treatment with both GABA agonists. In contrast, both
food intake and feeding duration decreased after injections of both doses of BIC (GABAA antagonist), while
the feeding latency remained unchanged after treatment with both GABA antagonists in the AcbSh of 24 h
food-deprived rats. The treatment with SAC (GABAB antagonist) did not affect feeding behaviour. Collective-
ly, these data suggest that emotional changes evoked by pharmacological manipulation of the GABA neuro-
transmission in the AcbSh are not linked with changes in food intake.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The nucleus accumbens (Acb) is a structure located in the basal
forebrain and is a major component of the ventral striatum (Zahm,
2000). It consists of two sub-regions, core and shell, which differ in
both anatomic organisation and functional properties (Kelley, 2004;
Voorn et al., 2004; Zahm, 2000; Zahm and Brog, 1992; Zahm and
Heimer, 1993). The manipulation of multiple neurotransmitter sys-
tems within the Acb has implicated this nucleus in the control of feed-
ing behaviour. The stimulation of both GABAA and GABAB stimulate
food intake in free-feeding rats as well as AMPA-type glutamate
receptor blockade in the nucleus accumbens shell (AcbSh) (Kelley
and Swanson, 1997; Maldonado-Irizarry et al., 1995; Stratford andleus accumbens; AcbSh, nucle-
agonist; BAC, baclofen, GABAB
agonist; SAC, Saclofen, GABAB
terior to the bregma suture;
e, anterior part.
ogical Sciences, CCB, Federal
SC, Brazil. Tel.: +55 48 3721
@ccb.ufsc.br (A.P.F. Lopes).
vier OA license.Kelley, 1997, 1999). In contrast, these GABA antagonists administered
into AcbSh decreased food intake in 24 h food-deprived rats (Kandov
et al., 2006). These effects on feeding are not observed with similar
injections into the nucleus accumbens core, lateral shell, or other
parts of the striatum (Basso and Kelley, 1999; Kelley and Swanson,
1997), supporting the hypothesis of a functional division among the
striatum.
Opioid-agonist injections into the AcbSh have been shown to in-
creased food intake, whereas opioid antagonists reduce consumption
(Kelley et al., 1996; Peciña and Berridge, 2000). Furthermore, the ac-
tivation of different serotonin receptor subtypes (5-HT1/7,6,4 in satiat-
ed rats by Pratt et al., 2009; 5-HT4 in satiated and deprived mice by
Jean et al., 2007) within themedial Acb also inﬂuences feeding behav-
iour in rodents. Neuropeptides were also identiﬁed in the AcbSh
circuits controlling feeding behaviour. It has been shown that the ac-
tivation of the AcbSh endocannabinoid CB1 or melanin-concentrating
hormone receptors resulted in a hyperphagic effect (Georgescu et al.,
2005; Guesdon et al., 2009; Kirkham et al., 2002; Soria-Gómez et al.,
2007). Therefore these studies suggest a strong relation between
food intake and AcbSh circuitry activation.
Although, traditionally, the AcbSh has not been considered a re-
gion involved in anxiety regulation, there is substantial evidence
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et al., 2008; Martinez et al., 2002; Pliakas et al., 2001; Reynolds and
Berridge, 2001, 2003; Sturm et al., 2003). This region receives connec-
tions of glutamatergic neurons from limbic areas such as the prefron-
tal cortex, ventral hippocampus and basolateral amygdale. It also
receives connections from other brain areas such as the lateral sep-
tum, amygdala, lateral hypothalamus area ventral tegmental, and
dorsal raphe nucleus and locus coeruleus (Brog et al., 1993), which
were all associated with stressful stimuli or anxiety (Aston-Jones
and Harris, 2004; Charney and Deutch, 1996; Picciotto et al., 2002).
The fact that the AcbSh is considered an interface between limbic
and motor systems (Mogenson et al., 1980) may explain its potential
role in anxiety-like behaviour.
We have been investigating the participation of GABA and gluta-
mate neurotransmission within AcbSh in an attempt to establish a rela-
tionship between food intake and fear/anxiety-related behaviours, as
patients with feeding disorders frequently exhibit symptoms of anxiety
and there is a high comorbidity between eating disorders and anxiety
disorders (Fornari et al., 1992; Mitchell et al., 1991). Previous studies
conducted in our laboratory showed that the activation of both
GABAA and GABAB receptors in the AcbSh decreased the level of fear/
anxiety and increased food intake in free-feeding animals, without a
positive correlation between both behaviours (Lopes et al., 2007).
Moreover, treatments with AMPA receptor antagonists induced
anxiolytic-like effects without affecting feeding behaviour (Da
Cunha et al., 2008a, 2008b). In the present work, we extend our stud-
ies on the relationship between food intake and fear/anxiety-related
behaviours, examining the effects of the injection of GABA agonists
and antagonists into the AcbSh on fear/anxiety-like behaviour tested
in the elevated plus-maze (EPM) followed by immediate recording of
feeding behaviour in the 24 h food-deprived rats since abstinence or
spontaneously emergent withdrawal is a more realistic condition of
animals in the wild or the human condition during famine or severe
dieting, and, in addition, anxiogenic-like behaviour has been demon-
strated in food restriction condition (Inoue et al., 2004).2. Materials and methods
2.1. Animals
Adult male Wistar rats weighing approximately 290 g were sup-
plied by the animal breeding division of the Federal University of
Santa Catarina (UFSC). The animals were housed in cages by groups
of 5 and submitted to a 7-day period of adaptation with food (CR-1,
Nuvilab) and water ad libitum with a light/dark cycle of 12 h (lights
on 6 am). The animals were only handled for weighing, drug admin-
istration, and cage cleaning.
All the experimental procedures described below were approved
by the University's Committee for Ethics in Animal Research (CEUA-
UFSC, protocol # PP00283/CEUA).2.2. Stereotaxic surgery
At least 7 days before the experiments, each animal was anaesthe-
tised by the intraperitoneal (i.p.) route with a ketamine hydro-
chloride (87 mg kg−1) and xylazine (13 mg kg−1) mixture. Bilateral
stainless steel guide cannulae (30 G) were implanted using stereotax-
ic techniques. The guide cannulae were aimed at sites located 2 mm
dorsal to medial AcbSh according to coordinates derived from the
Paxinos and Watson atlas (2007). The cannulae were anchored in
the skull with dental cement and the whole implant stabilised with
jeweller screws and more dental cement. A removable stylet was in-
troduced to keep the cannula free from blockages until the day of the
experiment.2.3. Drug injections
Injections were made through inner cannula (30 G) extending
2 mm beyond the ventral tip of the guide cannula connected by poly-
ethylene tubing to a Hamilton microsyringe (1 μl) ﬁtted to an injec-
tion pump. The injected volume was 0.2 μl of agonist or 0.5 μl of
antagonist administered bilaterally over a period of 60 s and a further
60 s was allowed for the solution to diffuse from the cannula. This rel-
atively high injection volume was necessary because of limited solu-
bility of the antagonists (see by Kandov et al., 2006; Stratford and
Kelley, 1997). The animals received a bilateral injection of muscimol
(MUS, GABAA receptor agonist, doses 25 and 50 ng/side, equivalent
to 128 and 256 pmol doses used in our previous study, Lopes et al.,
2007), baclofen (BAC, GABAB receptor agonist, doses 32 and 64 ng/
side, equivalent to 128 pmol and 256 pmol doses used in our previous
study, Lopes et al., 2007), bicuculline (BIC, GABAA receptor antago-
nist, doses 75 and 150 ng/side, doses derived from behaviour studies
carried out by Kandov et al., 2006) or saclofen (SAC, GABAB receptor
antagonist, doses 1.5 and 3 μg/side, doses derived from behaviour
studies carried out by Kandov et al., 2006). All drugs were purchased
from Aldrich-Sigma Chemical Company (St. Louis, USA) and freshly
dissolved in 0.9% sterile saline before the experiments.
2.4. Experimental procedures
During aweek after surgery the rats were housed individually with
free access to food and water. After this period, the animals were 24 h
food-deprived, but continued to have free access towater. Each animal
received only one drug-treatment to evaluate the effects of GABA ag-
onists and antagonist receptor injections into the AcbSh on anxiety-
like, ingestive and non-ingestive behaviours. After the injection, each
animal was placed on the central square of the elevated plus-maze
(EPM) facing an enclosed arm and was allowed to explore a maze
for 5 min. In sequence, the rats were transferred to the feeding record-
ing chamber to evaluate the ingestive and non-ingestive behaviours
for 30 min. Each experimental sessionwas recorded by a video camera
in an adjacent room and subsequently transcribed through the Etho-
log 2.25 software (Ottoni, 2000).
2.4.1. Anxiety-like behaviour
The elevated plus-maze (EPM) is one of the most used tests to
measure the anxiety-like behaviour in animal models. It consists of
two open and two closed arms of the same size (50 cm×10 cm) ar-
ranged in the form of a cross 50 cm above the ﬂoor; the arms were
connected by a central 10 cm×10 cm area. The two open arms were
surrounded by a short (1 cm) Plexiglas edge to keep the animals
from falling while the closed arms have 40 cm high opaque glass
walls, except for the entrance. Four 15 W ﬂuorescent lights arranged
across 100 cm above the maze were used as a source of illumination
and provided different levels of lux incidence on the open and closed
arms. The mean illumination level in the open arms and closed arms
were 373 and 284 lx respectively, with an 89 lx gradient of illumina-
tion between the open and closed arms. To avoid odoriferous cues be-
tween animals, the maze was cleaned with wet (alcohol 20%, v/v) and
dry cloths.
To evaluate the anxiety-like behaviour we used spatial–temporal
variables: number of entries into either open or enclosed arms
(arms entry and exit were deﬁned when all four paws were into
and or out of an arm), and the total number of entries. Exploratory
behaviour on the open arms was expressed by the mean percentage
of entries (%Open arm entries) and the time spent or percentage in
the open, centre and enclosed arm (%Open, Centre and Enclosed
arm time). The rat preference between the enclosed arms was evalu-
ated through the mean percentage of either entries or time spent in
the light enclosed arm. Additionally, ethologically derived measures
were also evaluated as follows: the total number of risk assessment
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enclosed and centre arms, in which the body is stretched forward
then retracted to the original position without any forward move-
ment); number of rearing (standing on their hind limbs); number
of head-dipping (protruding the head over the edge of an open arm
and scrutinising in the direction of the ﬂoor); and number of groom-
ing (cleaning any part of the body surface with the tongue, teeth, and/
or forepaws).
2.4.2. Food intake behaviour
Immediately after the exposure to the EPM test, each animal was
placed for 30 min in a feeding chamber containing standard rodent
chow and tap water. After this period the amount of food and water
consumed was measured. Throughout the experimental session, the
ingestive and non-ingestive behaviours were recorded by a video
camera perpendicularly located 60 cm above the chamber ﬂoor for
subsequent detailed analysis through Etholog 2.25 software (Ottoni,
2000). The feeding chamber was constructed with transparent glass
(49 cm×34 cm×32 cm). The back and lateral walls, as well as the
ﬂoor cage were coated with a black adhesive plastic paper. In order
to facilitate behavioural recording, the front wall of the test cage
had a mirror with the same dimensions arranged in a 45° angle inFig. 1. Photomicrograph and schematic representation of bilateral cannula placements in th
(25 ng/side, n=7, ■; 50 ng/side, n=7, ) and BAC (32 ng/side, n=7, ▲; 64 ng/side, n=6
side, n=7, ○) and SAC (1.5 μg/side, n=8, ●; 3 μg/side, n=8, ). The coronal sections
(2007) illustrating the distribution of the injection sites. All cannulae tips were localised wit
bens core; AcbSh: nucleus accumbens shell; aca: anterior commissure, anterior part.relation to the vertical plane. This mirror arrangement also prevented
the animal from seeing its reﬂection in the mirror.
The following variables were evaluated: feeding latency; duration
(amount of time the animal's mouth was either touching or chewing
a food pellet); grooming duration (deﬁned as paw strokes over the
face or licking of the paws or body); locomotion duration (deﬁned
as front-to-back chamber crossings); rearing duration (deﬁned as
front paws raised from the chamber ﬂoor); risk assessment duration
(see Section 2.4.1); and resting time (tucking head against chest
without movement for more than 5 s) (Rodgers et al., 1999). All the
experiments were carried out during the light phase of the cycle be-
tween 11:00 am and 3:00 pm.
2.5. Histological analysis
At the end of the experiments, the animals were deeply anaesthe-
tised and transcardially perfused with 0.9% saline followed by 10%
formalin. The brains were removed and subsequently cut (vibratome)
in the transverse plane (100 μm). Sections were stained with cresyl
violet and the cannula loci were examined and documented through
a camera lucida attached to a microscope. Cannula placements were
mapped onto the corresponding areas of the Atlas of The Rat Braine AcbSh in 75 rats receiving injection of vehicle (saline n=9, △), GABA agonist, MUS
, ), or vehicle (saline n=9, ), GABA antagonist, BIC (75 ng/side, n=7, □; 150 ng/
(scale bar=100 μm) of the rat brain according to the atlas of Paxinos and Watson
hin the AcbSh, 1.20 to 1.92 mm, anterior to the bregma structure. AcbC: nucleus accum-
Table 1
Effects of the bilateral injections of saline, GABAA (MUS) or GABAB (BAC) into the AcbSh of 24 h food-deprived rats on spatial–temporal and ethological variables, during 5 min of
exposure to the elevated plus-maze.
Variables Saline (n=9) MUS 25 (n=7) MUS 50 (n=7) BAC 32 (n=7) BAC 64 (n=6) ANOVA (main effects)
Open entries 5±0.5 3±1 4±1 2±0.7 5±0.9 F(4.31)=2.35; NS
Enclosed entries 6±1 8±1 6±1 5±0.9 8±2 F(4.31)=0.89; NS
Total entries 11±1 11±2 10±2 7±1 13±3 F(4.31)=1.61; NS
Open arms time 104±23 41±16 42±15 30±13 60±18 F(4.31)=2.94; NS
Centre arms time 45±9 48±18 67±39 79±26 72±26 F(4.31)=0.38; NS
Enclosed arms time 144±25 210±22 170±38 191±37 157±25 F(4.31)=0.78; NS
% Open arms entries 49±7 22±7 29±8 32±13 41±4 F(4.31)=1.73; NS
% Open arms time 36±8 14±5 14±5 10±4 20±6 F(4.31)=3.37; NS
% Centre arms time 19±5 15±6 22±13 26±9 24±9 F(4.31)=0.25; NS
% Enclosed arms time 42±9 70±7 56±13 63±12 52±8 F(4.31)=1.17; NS
Total risk assessment 1±0.2 0.1±0.1⁎ 0.3±0.2⁎ 0.3±0.2⁎ 0.2±0.2⁎ F(4.31)=4.34; pb0.0066⁎
Head dipping 5±1 5±1 4±1 3±1 5±1 F(4.31)=0.36; NS
Rearing 7±1 11±4 10±2 7±2 11±2 F(4.31)=0.73; NS
Grooming 3±0 3±0 2±1 1±0 2±0 F(4.31)=1.05; NS
Each column represents the mean±SEM. Numbers in parentheses refer to the number of animals examined for each treatment.
⁎ pb0.0125 compared to the control group.
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in the AcbSh were not included in the analyses.2.6. Statistical analysis
Separate one-way ANOVA tests were used to analyse the effects of
treatment with GABA agonists and GABA antagonists in the AcbSh on
anxiety-like, ingestive and non-ingestive behaviours. When appropri-
ate, the ANOVA tests were followed by a post-hoc Duncan's test
for multiple comparisons. The alpha level was adjusted using the
Bonferroni correction for pb0.0125 as we only considered the effec-
tive (4) comparisons made in our experiments; the results obtained
after each dose of GABAA or GABAB agonist injected into the accum-
bens shell vs. the control group (1—saline vs. MUS 25; 2—saline vs.
MUS 50; 3—saline vs. BAC 32; 4—saline vs. BAC 64). The same statis-
tical procedure was applied to the data obtained after each dose of
GABAA or GABAB antagonists.3. Results
3.1. Anxiety-like behaviour after treatment with GABA agonists and
antagonists in the AcbSh
Histological analysis indicated that 75 points of injection were
within the AcbSh. Fig. 1 shows sequential coronal sections of the in-
jection sites within the AcbSh.Table 2
Effects of the bilateral injections of saline, GABAA (BIC) or GABAB (SAC) into the AcbSh of
exposure to the elevated plus-maze.
Variables Saline (n=9) BIC 75 (n=7) BIC 150 (n=
Open entries 5±0.6 5±1 6±1
Enclosed entries 7±0.7 8±1 8±0.5
Total entries 12±1 13±1 14±2
Open arms time 71±11 62±19 63±16
Centre arms time 46±7 52±13 6±15
Enclosed arms time 182±13 185±28 147±22
% Open arms entries 45±4 35±5 36±8
% Open arms time 24±4 21±6 21±5
% Centre arms time 15±2 17±4 23±5
% Enclosed arms time 60±4 62±9 55±6
Total risk assessment 1±0.5 0.5±0.2 0.1±0.1
Head dipping 6±1 6±2 6±2
Rearing 11±1 9±2 7±2
Grooming 3±0.5 2±0.7 2±0.5
Each column represents the mean±SEM. Numbers in parentheses refer to the number of aThe one-way ANOVA revealed that only total number risk assess-
ment behaviour evaluated in EPM was signiﬁcantly affected by treat-
ment with GABA agonists [F(4,31)=4.34; p=0,0066]. The total
number of risk assessment behaviour decreased after the injection
of both doses of GABAA agonist (MUS) into the AcbSh of 24 h food-
deprived rats. Similar results were obtained after treatment with
both doses of GABAB (BAC) agonist in the AcbSh. The other etho-
logical behaviours and spatial–temporal parameters remained
unchanged after bilateral injection of both GABAA and GABAB ago-
nists into the AcbSh (Table 1). The one-way ANOVA indicated that
both spatial–temporal parameters (number of entries into either
open or enclosed arms; total number of entries; % open arm entries
and the time spent or percentage into the open, centre and enclosed
arm) and ethological behaviours (total number of risk assessment,
number of head dipping, number of rearing, number of grooming)
remained unchanged after treatment with both doses of GABAA
(BIC) and GABAB (SAC) antagonists in the AcbSh of 24 h food-
deprived rats (Table 2).3.2. Ingestive behaviour after treatment with GABA agonists and
antagonists in the AcbSh
Feeding behaviour (food intake, feeding latency and feeding
duration) was not affected by bilateral injections of either GABA ago-
nists into AcbSh of 24 h food-deprived rats (Fig. 2A). The one-way
ANOVA showed that the other non-ingestive behaviours evaluated
during feeding register (locomotion, resting, risk assessment, rearing24 h food-deprived rats on spatial–temporal and ethological variables, during 5 min of
7) SAC 1.5 (n=8) SAC 3.0 (n=8) ANOVA (main effects)
5±1 3±1 F(4.34)=0.63; NS
5±1 5±0.6 F(4.34)=2.18; NS
10±2 9±1 F(4.34)=1.75; NS
102±33 58±24 F(4.34)=0.65; NS
88±28 35±13 F(4.34)=1.55; NS
109±32 207±35 F(4.34)=2.02; NS
48±7 30±11 F(4.34)=0.88; NS
34±11 19±8 F(4.34)=0.65; NS
29±9 11±4 F(4.34)=1.55; NS
36±11 69±11 F(4.34)=1.95; NS
0.5±0.3 1±0.5 F(4,34)=1.40; NS
7±2 5±1 F(4.34)=0.27; NS
8±2 9±3 F(4.34)=1.19; NS
2±0.6 2±0.3 F(4.34)=0.44; NS
nimals examined for each treatment.
Fig. 2. Effects of bilateral injections of saline, GABAA and GABAB agonists (A) or antagonists (B) into the AcbSh of the 24 h food-deprived rats on food intake, feeding latency and
feeding duration, during 30 min exposure to the feeding chamber. Each column represents the mean±S.E.M. *pb0.0125 compared to the control group (one-way ANOVA followed
by Duncan test for multiple comparisons and Bonferroni correction).
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intake [F(4,34)=3.66; p=0.01] and feeding duration [F(4,34)=
5.21; p=0.002] were signiﬁcantly affected by treatment with both
GABA antagonist in the AcbSh of 24 h food-deprived rats. While
both food intake and feeding duration decreased after injections of
both doses of BIC (GABAA antagonist), the feeding latency remained
unchanged after treatment with both GABA antagonists in the
AcbSh of 24 h food-deprived rats (Fig. 2B). The injection with both
doses of GABAB antagonist into the AcbSh did not affect feeding be-
haviour. Non-ingestive behaviours remained unchanged after the
treatment with both GABA antagonists (Table 4).
4. Discussion
The risk assessment data indicate that the activation of both
GABAA and GABAB receptors within the AcbSh caused anxiolysis inTable 3
Durations of non-ingestive behaviours (seconds) during 30 min in the feeding chamber tes
AcbSh in 24 h food-deprived rats.
Behaviour durations (seconds) Saline (n=9) MUS 25 (n=7) MUS 5
Locomotion 143±33 158±40 75±1
Resting time 51±33 20±19 16±8
Risk assessment (SAP) 0±0 1±1 1±0
Rearing 66±21 106±32 32±5
Grooming 123±27 101±29 97±2
All data are expressed in seconds. Numbers in parentheses refer to the number of animals24 h food-deprived rats since the injections of both doses of the
GABAA receptor agonists (MUS) and GABAB receptor agonist (BAC)
decreased the total number of risk assessment exhibition in 24 h
food-deprived rats exposed to EPM. In our previous study the anxio-
lytic effect evoked by GABAA and GABAB agonists injected into the
AcbSh of free-feeding rats was also indicated by a decrease in the
total number of risk assessment. The spatial–temporal variables
such as % open arms time and open arms entries showed a marginal
signiﬁcant trend to increase, reinforcing the anxiolytic effect induced
by GABA agonists. In the present study, the spatial–temporal vari-
ables were not affected by treatment with GABAA or GABAB agonists.
The modest changes in the risk assessment could not provide
compelling evidence that the rats are in a lesser anxious state follow-
ing drug treatment. However, our present data added to our previous
result (Lopes et al., 2007) strengthens the anxiolytic effect evoked by
GABA agonist in the AcbSh. A possible reason for the lowest riskt, under effects of bilateral injections of saline, GABAA (MUS) or GABAB (BAC) into the
0 (n=7) BAC 32 (n=7) BAC 64 (n=6) ANOVA (main effects)
7 90±23 107±40 F(4,31)=1.16; NS
40±21 28±28 F(4,31)=0.89; NS
7±6 0±0 F(4,31)=1.07; NS
27±7 44±18 F(4,31)=2.53; NS
9 98±27 95±27 F(4,31)=0.18; NS
examined for each treatment.
Table 4
Durations of non-ingestive behaviours (seconds) during 30 min in the feeding chamber test, after the bilateral injections of saline, GABAA (BIC) or GABAB (SAC) into the AcbSh in
24 h food-deprived rats.
Behaviour durations (seconds) Saline (n=9) BIC 75 (n=7) BIC 150 (n=7) SAC 1.5 (n=8) SAC 3.0 (n=8) ANOVA (main effects)
Locomotion 112±20 166±31 127±61 83±18 65±22 F(4,34)=1.42; NS
Resting time 0.3±0.2 131±48 61±26 95±39 47±31 F(4,34)=0.91; NS
Risk assessment (SAP) 0±0 1±0 0±0 0±0 0±0 F(4,34)=0.81; NS
Rearing 45±8 67±13 72±36 52±12 27±10 F(4,34)=0.81; NS
Grooming 102±32 129±30 121±44 160±44 117±29 F(4,34)=0.24; NS
All data are expressed in seconds. Numbers in parentheses refer to the number of animals examined for each treatment.
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reported that after acute and chronic food restriction, and after
10 days refeeding, rats increased open arm exploration compared to
rats with continuous food access (Genn et al., 2003; Inoue et al.,
2004). This data indicate that food-deprived rats were less anxious
than satiated rats. Our previous (Lopes et al., 2007) and present
data conﬁrm this emotional inﬂuence while the total number of risk
assessment exhibited by 24 h food-deprived rats under control condi-
tions was 1±0.2, this number was 4±0.6 for free-feeding rats (Lopes
et al., 2007). This difference was also statistically signiﬁcant according
to t test, t=3.91 p=0.000368. Furthermore, the anxiety state indi-
cated by % open arms time under control conditions in the free-
feeding was 12±3 (n=22) (Lopes et al., 2007) and in the 24 h
food-deprived rats was 30±4 (n=18). This difference was also sta-
tistically signiﬁcant according to t test, t=3.61 p=0.00087, and indi-
cates that the 24 h food-deprived rats spent more time in the open
arms than free-feeding rats. Therefore, our results conﬁrm that the
nutritional condition affects the anxiety expression.
This anxiolytic-like effect associated to food deprivation could not
be attributed to an increased motivation to forage for food or nonspe-
ciﬁc behavioural activation as opposed to a genuine decrease in
anxiety-like behaviour because rats did not exhibit increased closed
arm entries, an index of locomotor/exploratory activity. Moreover,
rats also continued to exhibit anxiolytic-like changes after refeeding,
despite normalisation of energy balance (Inoue et al., 2004). In addi-
tion, defensive burying behaviour, an active anxiogenic-like response
unrelated to exploratory drive, was also reduced during food depriva-
tion (Davis et al., 1981).
The anxiolytic effects caused by GABAA (Crestani et al., 2002; Kash
et al., 1999; Rudolph et al., 1999; Sasaki et al., 2002; Stork et al., 2003)
and GABAB (Cryan et al., 2004; Cryan and Kaupmann, 2005; Davi and
Rodgers, 1996; Jacobson et al., 2007; Mombereau et al., 2004a, 2004b)
receptors have been extensively described. In contrast, the fear/
anxiogenic effect associated to GABAA receptor activation was also
documented. It has been shown that the injection of MUS into the
AcbSh evoked a strong defensive burying or paw-treading behaviour
(Reynolds and Berridge, 2001), a contradictory effect found when
compared with our previous or present data. The anxiolytic effect
mediated by both GABAA and GABAB receptor activation in both
food-deprived rats (present results) and free-feeding rats (Lopes
et al., 2007) could be attributed to different microinjection sites
(rostral×caudal) within AcbSh. While the anxiolytic response was
elicited by GABA agonists injected into the rostral sites within AcbSh
(AP: +1.20 to +1.68 mm) in a previous work and (AP: +1.20 to
+1.92 mm) in the present study, the defensive behaviour in rats was
elicited by GABAA receptor agonist injected at more caudal sites (AP:
+1.20 to +0.48 mm). However, a fear/anxiogenic response was
also observed after GABAA injection in the rostral parts of AcbSh
(Reynolds and Berridge, 2001). We do not have an explanation for the
contrasting effect on animal emotionality after GABA agonist injection
into the AcbSh, but our present data strengthen the anxiolytic effect
evoked by both GABAA and GABAB receptor activation within AcbSh.
The present study also showed that feeding behaviour was not af-
fected by bilateral injection of both GABA agonists, MUS and BAC,injected into the AcbSh of 24 h food-deprived rats. Similar results
were observed after systemic injection of BAC in 22 h food deprived
rats (Ebenezer, 1996; Ebenezer and Patel, 2011). In contrast, in the
free-feeding animals, treatment with both GABA agonists in the
AcbSh had a hyperphagic response accompanied by an increase in
feeding duration (Kelley et al., 2005; Lopes et al., 2007; Reynolds
and Berridge, 2001; Soderpalm and Berridge, 2000; Stratford and
Kelley, 1997, 1999). The lack of effects on feeding behaviour after in-
jection of GABA agonists into AcbSh of food-deprived rats could be at-
tributed to an intense occupation of GABAB (known to be localised on
glutamate nerve terminals) or GABAA (located on output medium-
spiny neurons) receptor due to intense stimulation of gabergic pro-
jections to AcbSh neurons that could result in elimination of AcbSh
inhibitory inﬂuences on hypothalamic feeding-related circuitry, pro-
viding a hungry rat a prompt to start feeding (Kelley et al., 2005).
In the present result we showed that the GABAA receptor blockade
by injection of GABAA receptor antagonists into the AcbSh of 24 h
food-deprived rats evoked decreased food intake accompanied by re-
duction in the feeding duration. This data suggest the presence of
neural impulses mediated by GABAA receptors within AcbSh that
elicit feeding motivation in hungry rats and reinforce our previous
suggestion that in food deprived conditions the occupation of
GABA receptors within AcbSh could be intense. The participation of
GABAB receptors mediating feeding motivation cannot be excluded
since injections of GABAB receptor antagonist into AcbSh of 24 h
food-deprived rats also resulted in hypophagia (Kandov et al., 2006).
The reason for the lack of hypophagic effect after the GABAB receptor
blockade within the AcbSh in the present study could be attributed to
a lower recording time (30 min) than the one registered by Kandov et
al. (2006) (from 30 min to 4 h). Furthermore, Patel and Ebenezer
(2004) have shown that the intracerebroventricular (icv) administra-
tion of the GABAB receptor antagonist CGP 35348 decreased feeding in
22 h fasted rats, 15 min after injection. The rapid onset of the hypo-
phagia evoked by GABAB receptor antagonist may have been due to
an action at a site outside the nucleus accumbens, suggesting the in-
volvement of other central areas in the mediation of GABAB effect on
feeding motivation.
It has been proposed that both GABAA and GABAB antagonists are
functionally involved in the maintenance, but not in the initiation of
deprivation-induced food intake, since both GABA antagonists failed
to affect food intake 30 min after the injection into the AcbSh
(Kandov et al., 2006). However, the blockade of GABAA receptor
resulted in food intake decrease accompanied by a reduction in feed-
ing duration, without affecting feeding latency. An alteration in feed-
ing duration has also been observed after GABAA receptor activation
in free-feeding rats within the AcbSh. Taken together, these data rein-
force our previous suggestion that GABAA circuitry within AcbSh
could interfere with signals arising from the digestory tract to control
meal size (Heisler and Tecott, 2000; Inoue et al., 1994; Jean et al.,
2007).
We have reported that manipulations of both GABA and gluta-
mate neurotransmission within the Acb inﬂuence feeding and fear/
anxiety-related behaviours without establishing functional relation-
ships between the two factors. Treatment with AMPA receptor
47A.P.F. Lopes et al. / Pharmacology, Biochemistry and Behavior 101 (2012) 41–48antagonists induced anxiolytic-like effects in the EPM and, as evalu-
ated by the reduction of stretched-attend postures in the feeding
test, without modifying feeding behaviour (Da Cunha et al., 2008a,
2008b). Bilateral injections of either GABAA or GABAB agonist recep-
tors into the AcbSh induced an anxiolytic-like effect and increased
food intake, but without positive correlations between the two pa-
rameters (Lopes et al., 2007). In the present study we showed that,
while the stimulation of GABAA and GABAB receptor agonists
evoked an anxiolytic effect, feeding behaviour remained unchanged.
Furthermore, while both GABAA and GABAB antagonists injected
into the AcbSh did not affect the anxiety-like behaviours, both
doses of GABAA antagonist caused a hypophagic response. Collec-
tively, these data suggest that emotional changes evoked by phar-
macological manipulation of the GABA neurotransmission in the
AcbSh are not linked with changes in food intake.
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